Choksi Laboratories Ltd
06 Nov 2026 12:00 AM
Choksi Laboratories to convene board meeting November 14 to review financial results,
Choksi Laboratories Limited will hold a meeting of its Board of Directors on November 14, 2026, at 12:30 P.M. to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026, according to a regulatory filing with the BSE Limited. The trading window for dealing in the company`s securities will open 48 hours after the declaration of the unaudited financial results for designated persons, their immediate relatives, and connected persons, following the closure of the trading window from October 1, 2026.
Choksi Laboratories Ltd
19 Oct 2026 12:00 AM
Choksi Laboratories’ convertible warrant issuance proposal failed shareholder approval Saturday,
Choksi Laboratories Limited informed the BSE Limited that a proposal for the preferential issue of convertible warrants, which was presented to shareholders at an Extra-Ordinary General Meeting on Saturday, October 17, 2026, was not approved, and the company will therefore not proceed with the issuance. The company’s promoters and proposed allottees abstained from voting on the resolution, and Choksi Laboratories Limited has requested BSE Limited to close the application for in-principle approval related to the proposed preferential issue.
Choksi Laboratories Ltd
05 Oct 2026 12:00 AM
Choksi Laboratories Limited confirmed regulatory compliance for the quarter ended September 30, 2026,
Choksi Laboratories Limited, on October 5, 2026, submitted a certificate to the BSE Limited concerning the compliance of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026, as confirmed by Ankit Consultancy Pvt. Ltd., the company`s registrar and share transfer agent.
Choksi Laboratories Ltd
26 Sep 2026 12:00 AM
Choksi Laboratories closes trading window for insiders starting October 1, 2026,
Choksi Laboratories Limited informed the BSE Limited that it will close the trading window for its shares for all designated persons, their immediate relatives, and connected persons, starting October 1, 2026, until 48 hours after the declaration of the company’s unaudited financial results for the quarter and half year ended September 30, 2026. The company also stated that it has complied with SEBI circulars dated August 5, 2022, July 19, 2023, and April 21, 2025, regarding trading window closure and freezing of PAN at the security level.
Choksi Laboratories Ltd
24 Sep 2026 12:00 AM
Choksi Laboratories to allot warrants to promoters, increasing their stake to 34.76%,
Choksi Laboratories Limited plans a preferential allotment of 350,000 convertible warrants to promoters Sunil Kumar Choksi, Himika Choksi, and Stela Choksi, increasing the promoter group’s stake from 31.48% to 34.76%. The allotment, compliant with the Companies Act, 2013, SEBI regulations, and BSE listing requirements, will be conducted for cash and is not expected to trigger takeover regulations. While the issue and conversion prices were not disclosed, the move will dilute existing shareholders’ ownership. The warrants and resulting shares will be subject to lock-in periods, and the company’s management and control will remain unchanged. The board recommends shareholder approval, and relevant documents are available for inspection at the company’s registered office.
Subscribe for our
newsletter
newsletter
HSL Mobile App